Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 8 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 4

1(12.5%)

8Total

N/A(7)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06345950Not ApplicableCompleted

Pharmacokinetics and Safety of a New Micellar Glutathione Formulation

Role: lead

NCT06202157Not ApplicableCompleted

Metabolic Differences Between Dihydroberberine and Micellar Berberine

Role: lead

NCT06151171Not ApplicableCompleted

Pharmacokinetics of Different CoQ10 Formulations

Role: lead

NCT05209425Not ApplicableCompleted

Pharmacokinetics Evaluation of Vitamin D Formulations

Role: lead

NCT05394701Not ApplicableCompleted

Comparing the Pharmacological Profile of Formulations Containing Omega 3 Fatty Acids

Role: lead

NCT05370261Not ApplicableCompleted

Pharmacological Profile of Different Berberine Formulations, and Effects on Blood Sugar Levels

Role: lead

NCT05611827Not ApplicableCompleted

Pharmacological Profile of Different Quercetin Formulations

Role: lead

NCT01427426Phase 4Completed

Does a Nutritional Supplement Increase Vitality, Energy and Perceived Well Being?

Role: collaborator

All 8 trials loaded